Long-term survival in multiple myeloma.

Clin Case Rep

Department of Hematology, IPOFG Lisboa, Portugal ; Clinical Research Unit, IPOFG Lisboa, Portugal.

Published: October 2014

The survival of multiple myeloma patients has improved very significantly over the last decade. Still median overall survival is inferior to 5 years. A small proportion of patients survive longer than 10 years. In this paper we discuss four cases illustrating the nonhomogeneous clinical presentation and evolution of this subset of patients. Surprisingly, these long survivors do not always have deep responses and some require frequent treatments, which include autologous stem cell transplantation and novel drugs. The authors discuss several aspects of these clinical histories, including treatment options, raising hypothesis on their relation with long survivorship which may be important to have in consideration when studying this subject.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302619PMC
http://dx.doi.org/10.1002/ccr3.76DOI Listing

Publication Analysis

Top Keywords

survival multiple
8
multiple myeloma
8
long-term survival
4
myeloma survival
4
myeloma patients
4
patients improved
4
improved decade
4
decade median
4
median survival
4
survival inferior
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!